No abstract
Cardiovasc Diabetol. 2026 Feb 22. doi: 10.1186/s12933-026-03117-z. Online ahead of print.
NO ABSTRACT
PMID:41724932 | DOI:10.1186/s12933-026-03117-z
Erythrocytosis after SGLT2 inhibitor initiation and anticoagulated outcomes in atrial fibrillation: a real-world analysis with counterfactual modeling
Scritto il 22/02/2026